首页 | 本学科首页   官方微博 | 高级检索  
检索        

HBeAg 阴性慢性乙型肝炎患者血清胱抑素C水平及其临床价值
引用本文:王晓亮,唐生尧,刘国生,周维,郑建琼,周发为.HBeAg 阴性慢性乙型肝炎患者血清胱抑素C水平及其临床价值[J].国际检验医学杂志,2014,0(13):1729-1731.
作者姓名:王晓亮  唐生尧  刘国生  周维  郑建琼  周发为
作者单位:王晓亮(湖北民族学院附属民大医院检验科,湖北恩施,445000);唐生尧(湖北民族学院附属民大医院检验科,湖北恩施,445000);刘国生(湖北民族学院附属民大医院检验科,湖北恩施,445000);周维(湖北民族学院附属民大医院检验科,湖北恩施,445000);郑建琼(湖北民族学院附属民大医院检验科,湖北恩施,445000);周发为(湖北民族学院附属民大医院检验科,湖北恩施,445000);
摘    要:目的:探讨乙型肝炎病毒 e 抗原(HBeAg)阴性慢胜乙型肝炎(CHB)患者血清胱抑素 C(CysC)水平变化及其临床价值。方法选取在该院就诊的212例 CHB 患者,根据 HBeAg 特点分为阴性组和阳性组,选取105例健康者作为对照组,检测血清 CysC、ALT 、AST、Cr、BUN、HBV DNA 水平。Pearson 相关分析法判断 HBeAg 阴性 CHB 患者 CysC 与 ALT 、AST、Cr、BUN、HBV DNA 水平的相关性。结果HBeAg 阴性 CHB 患者组的 CysC 水平(1.40±0.36)mg/L 高于对照组(0.93±0.12) mg/L 和 HBeAg 阳性 CHB 患者组(0.96±0.18)mg/L,差异有统计学意义(P <0.05);HBeAg 阴性 CHB 患者组的 CysC 水平与肾功能的 Cr 水平呈明显的正相关(r=0.840,P <0.01)。结论CysC 可作为监测 HBeAg 阴性 CHB 患者的早期肾损害的有效指标,对疾病的防治有重要的临床意义。

关 键 词:肝炎  乙型  慢性  半胱氨酸蛋白酶抑制剂  肾损害

Level and clinical value of serum cystain C in patients with HBeAg-negative chronic hepatitis B
Wang Xiaoliang,Tang Shengyao,Liu Guosheng,Zhou Wei,Zheng Jianqiong,Zhou Fawei.Level and clinical value of serum cystain C in patients with HBeAg-negative chronic hepatitis B[J].International Journal of Laboratory Medicine,2014,0(13):1729-1731.
Authors:Wang Xiaoliang  Tang Shengyao  Liu Guosheng  Zhou Wei  Zheng Jianqiong  Zhou Fawei
Institution:(Department of Clinical Laboratory,Affiliated Minda Hospital, Hubei University for Nationalities, Enshi , Hubei 445000,China)
Abstract:Objective To investigate the change and clinical value of serum cystain C(CysC)level in the patients with HBeAg-negative chronic hepatitis B(CHB).Methods 212 cases of CHB in our hospital were selected and divided into the HBeAg-negative group and the HBeAg-positive group according to the HBeAg status.105 healthy individuals at the same time were enrolled as the control group.The levels of serum CysC,ALT,AST,Cr,BUN and HBV DNA in 3 groups were detected and compared.The corre-lations between serum CysC with AST,AST,Cr,Bun,HBV DNA were analyzed by the Pearson correlation analysis.Results The mean CysC level in the HBeAg-negative group was (1 .40±0.36)mg/L,which was higher than (0.93±0.12)mg/L in the control group and (0.96±0.18)mg/L in the HBeAg-positive group,the differences between them was statistically significant(P 〈0.05). The CysC was significantly positively correlated with serum Cr level in the HBeAg-negative group(r=0.840,P 〈0.01).Conclusion The CysC level might be used as an effective index for monitoring the early kidney injury in the patients with HBeAg-negative CHB,which has important significance in the prevention and treatment of HBeAg-negative CHB.
Keywords:hepatitis B  chronic  cysteine proteinase inhibitors  kidney injury
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号